Those studies have shown that EWSR1–FLI1 knockdown impairs proliferation of Ewing sarcoma cells both in vitro and in vivo, reinforcing the idea that EWSR1–FLI1 targeted inactivation should be the most effective therapy against Ewing sarcoma [19]. The gene discussed is FLI1; the disease is Ewing sarcoma.